Page last updated: 2024-10-24

calmidazolium and Cardiac Failure

calmidazolium has been researched along with Cardiac Failure in 2 studies

calmidazolium: powerful inhibitor of or red blood cell Ca++-ATPase & Ca++ transport into inside-out red blood cell vesicles; RN refers to chloride; structure in first source; an antagonist of calmodulin
calmidazolium : An imidazolium ion that is imidazolium cation substituted by a bis(4-chlorophenyl)methyl group at position 1 and a 2-[(2,4-dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl group at position 3. It acts as an antagonist of calmodulin, a calcium binding messenger protein.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Colston, JT1
Kumar, P1
Chambers, JP1
Freeman, GL1
Silver, PJ1
Monteforte, PB1

Other Studies

2 other studies available for calmidazolium and Cardiac Failure

ArticleYear
Altered sarcolemmal calcium channel density and Ca(2+)-pump ATPase activity in tachycardia heart failure.
    Cell calcium, 1994, Volume: 16, Issue:5

    Topics: Animals; Calcium; Calcium Channels; Calcium-Transporting ATPases; Cardiac Pacing, Artificial; Enzyme

1994
Differential effects of pharmacological modulators of cardiac myofibrillar ATPase activity in normal and myopathic (BIO 14.6) hamsters.
    European journal of pharmacology, 1988, Mar-15, Volume: 147, Issue:3

    Topics: Adenosine Triphosphatases; Animals; Anti-Arrhythmia Agents; Bepridil; Calcium; Calcium Channel Block

1988